Hasan Akbaba

717 total citations
34 papers, 556 citations indexed

About

Hasan Akbaba is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Hasan Akbaba has authored 34 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 7 papers in Immunology. Recurrent topics in Hasan Akbaba's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Hasan Akbaba is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Hasan Akbaba collaborates with scholars based in Türkiye, United States and Germany. Hasan Akbaba's co-authors include Gülşah Erel‐Akbaba, Ayşe Gülten Kantarcı, Mustafa Kotmakçı, Yücel Başpınar, Bakhos A. Tannous, E. Antonio Chiocca, Tian Tian, Pierre J. Obeid, Max Zinter and Ralph Weissleder and has published in prestigious journals such as ACS Nano, Nature Immunology and Scientific Reports.

In The Last Decade

Hasan Akbaba

32 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasan Akbaba Türkiye 11 222 170 157 106 74 34 556
Fatemeh Movahedi Australia 14 176 0.8× 198 1.2× 174 1.1× 76 0.7× 46 0.6× 21 472
Nehal E. Elsadek Egypt 10 297 1.3× 201 1.2× 125 0.8× 93 0.9× 58 0.8× 17 614
Jia Cai China 10 203 0.9× 178 1.0× 231 1.5× 85 0.8× 43 0.6× 20 538
Wuji Cao United States 9 346 1.6× 174 1.0× 156 1.0× 95 0.9× 31 0.4× 10 593
Nathaly Segovia Spain 5 305 1.4× 156 0.9× 143 0.9× 46 0.4× 61 0.8× 6 500
Peeyush N. Goel India 14 258 1.2× 226 1.3× 128 0.8× 98 0.9× 97 1.3× 24 622
Zi-Xian Liao Taiwan 9 279 1.3× 201 1.2× 158 1.0× 45 0.4× 74 1.0× 14 531
Julio M. Rios De La Rosa United Kingdom 10 272 1.2× 231 1.4× 213 1.4× 67 0.6× 76 1.0× 12 650
Yingwen Hu China 11 206 0.9× 295 1.7× 230 1.5× 45 0.4× 55 0.7× 15 568
Sukyung Ahn South Korea 8 210 0.9× 147 0.9× 152 1.0× 147 1.4× 43 0.6× 9 474

Countries citing papers authored by Hasan Akbaba

Since Specialization
Citations

This map shows the geographic impact of Hasan Akbaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Akbaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Akbaba more than expected).

Fields of papers citing papers by Hasan Akbaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasan Akbaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Akbaba. The network helps show where Hasan Akbaba may publish in the future.

Co-authorship network of co-authors of Hasan Akbaba

This figure shows the co-authorship network connecting the top 25 collaborators of Hasan Akbaba. A scholar is included among the top collaborators of Hasan Akbaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasan Akbaba. Hasan Akbaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mora‐Buch, Rut, et al.. (2025). IL-4 impairs the formation of skin-resident memory CD8+ T cells. Nature Immunology. 26(8). 1329–1338. 1 indexed citations
2.
Karakavuk, Muhammet, Hüseyin Can, Aysu Değirmenci Döşkaya, et al.. (2025). Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis. Scientific Reports. 15(1). 32979–32979.
3.
Erel‐Akbaba, Gülşah, et al.. (2025). Microfluidics Based Particle and Droplet Generation for Gene and Drug Delivery Approaches. Journal of Biomedical Materials Research Part B Applied Biomaterials. 113(2). e35530–e35530. 1 indexed citations
4.
Singh, Parbeen, et al.. (2025). Enhancing vaccine stability in transdermal microneedle platforms. Drug Delivery and Translational Research. 15(10). 3414–3438. 2 indexed citations
5.
Karakavuk, Muhammet, Hüseyin Can, Aysu Değirmenci Döşkaya, et al.. (2024). A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis. Vaccine. 42(24). 126065–126065. 4 indexed citations
6.
Erel‐Akbaba, Gülşah, et al.. (2022). Octaarginine functionalized nanoencapsulated system: In vitro and in vivo evaluation of bFGF loaded formulation for wound healing. Journal of Drug Delivery Science and Technology. 71. 103343–103343. 9 indexed citations
7.
Ekinci, Meliha, Clenilton Costa dos Santos, Luciana Magalhães Rebêlo Alencar, et al.. (2022). Atezolizumab-Conjugated Poly(lactic acid)/Poly(vinyl alcohol) Nanoparticles as Pharmaceutical Part Candidates for Radiopharmaceuticals. ACS Omega. 7(51). 47956–47966. 4 indexed citations
8.
Akbaba, Hasan, İbrahim Çavuş, Črtomir Podlipnik, et al.. (2022). Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition. European Journal of Medicinal Chemistry. 247. 115049–115049. 10 indexed citations
9.
Erel‐Akbaba, Gülşah & Hasan Akbaba. (2021). Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing. DARU Journal of Pharmaceutical Sciences. 29(2). 329–340. 8 indexed citations
10.
Erel‐Akbaba, Gülşah & Hasan Akbaba. (2021). A comparative study of cationic liposomes for gene delivery. Journal of Research in Pharmacy. 25(4)(25(4)). 398–406. 3 indexed citations
11.
12.
Bromley, Shannon K., et al.. (2020). CD49a Regulates Cutaneous Resident Memory CD8+ T Cell Persistence and Response. Cell Reports. 32(9). 108085–108085. 71 indexed citations
13.
Erel‐Akbaba, Gülşah, et al.. (2020). Development and Evaluation of Solid Witepsol Nanoparticles for Gene Delivery. Turkish Journal of Pharmaceutical Sciences. 18(3). 344–351. 9 indexed citations
14.
Akbaba, Hasan, Gülşah Erel‐Akbaba, Mustafa Kotmakçı, & Yücel Başpınar. (2020). Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells. Pharmaceutical Research. 37(8). 165–165. 26 indexed citations
15.
Başpınar, Yücel, Gülşah Erel‐Akbaba, Mustafa Kotmakçı, & Hasan Akbaba. (2019). Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer. International Journal of Pharmaceutics. 566. 149–156. 26 indexed citations
16.
Başpınar, Yücel, Hasan Akbaba, & Oğuz Bayraktar. (2019). Encapsulation of paclitaxel in electrosprayed chitosan nanoparticles. Journal of Research in Pharmacy. 23(5). 886–896. 5 indexed citations
17.
Akbaba, Hasan, et al.. (2018). Implementation of a prosthetic labelling process in implant-supported fixed prosthesis and comparison of two different methods: an in vitro study. Egyptian Journal of Forensic Sciences. 8(1). 1 indexed citations
18.
Akbaba, Hasan, Gülşah Erel‐Akbaba, & Ayşe Gülten Kantarcı. (2018). Development and evaluation of antisense shRNA-encoding plasmid loaded solid lipid nanoparticles against 5-α reductase activity. Journal of Drug Delivery Science and Technology. 44. 270–277. 16 indexed citations
19.
20.
Akbaba, Hasan, et al.. (1997). Drying model for α-amylase in a horizontal spray dryer. Journal of Food Engineering. 31(4). 499–510. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatemeh Movahedi Breakdown of academic impact, for papers by Nehal E. Elsadek Breakdown of academic impact, for papers by Jia Cai Breakdown of academic impact, for papers by Wuji Cao Breakdown of academic impact, for papers by Nathaly Segovia Breakdown of academic impact, for papers by Peeyush N. Goel Breakdown of academic impact, for papers by Zi-Xian Liao Breakdown of academic impact, for papers by Julio M. Rios De La Rosa Breakdown of academic impact, for papers by Yingwen Hu Breakdown of academic impact, for papers by Sukyung Ahn
Rankless by CCL
2026